Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Total Liabilities (2017 - 2025)

Historic Total Liabilities for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $76.2 million.

  • Q32 Bio's Total Liabilities fell 1161.2% to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year decrease of 1161.2%. This contributed to the annual value of $86.7 million for FY2024, which is 2689.21% down from last year.
  • Q32 Bio's Total Liabilities amounted to $76.2 million in Q3 2025, which was down 1161.2% from $78.4 million recorded in Q2 2025.
  • In the past 5 years, Q32 Bio's Total Liabilities ranged from a high of $118.5 million in Q4 2023 and a low of $32.2 million during Q3 2021
  • Over the past 5 years, Q32 Bio's median Total Liabilities value was $51.9 million (recorded in 2023), while the average stood at $63.5 million.
  • In the last 5 years, Q32 Bio's Total Liabilities crashed by 4594.86% in 2021 and then surged by 13475.6% in 2023.
  • Quarter analysis of 5 years shows Q32 Bio's Total Liabilities stood at $42.1 million in 2021, then rose by 20.02% to $50.5 million in 2022, then skyrocketed by 134.76% to $118.5 million in 2023, then fell by 26.89% to $86.7 million in 2024, then fell by 12.03% to $76.2 million in 2025.
  • Its Total Liabilities stands at $76.2 million for Q3 2025, versus $78.4 million for Q2 2025 and $83.1 million for Q1 2025.